Episode 32: An Education in Biotech, Dev Gandhi - SilverArc Capital

If you ever want to cause a debate with any of your investment friends, a good starter subject is BioTech. People either love it or hate it. Biotech stocks are particularly volatile. The day trial results are released can see a stock falling 50% or gaining 100%. In addition, it takes a high level of scientific and medical expertise to even understand the drugs. 

At the same time, we are living through a period of tremendous scientific discovery.   For all of these reasons, we see Biotech as an area of the stock market full of inefficiency. To make sense of it, I’ve invited Dev Gahndi, Founder and CIO of SilverArc Capital to join for an in depth conversation on Biotech investing. 

This podcast was recorded on September 5,  2023.  The respective opinions expressed are those of Mr. Gandhi and the Biltmore Family Office, LLC investment team.  The opinions referenced are as of the date of this podcast and are subject to change without notice.  This material is for informational use only and should not be considered investment advice. The information discussed herein is not a recommendation to buy or sell a particular security or to invest in any particular sector.  Forward-looking statements are not guaranteed.  BFO reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs and there is no guarantee that their assessment of investments will be accurate.  The discussions, outlook and viewpoints featured are not intended to be investment advice and do not take into account specific client investment objectives.  Before investing, an investor should consider his or her investment goals and risk comfort levels and consult with his or her investment adviser and tax professional.  

Biltmore Family Office, LLC is an investment adviser registered with the U.S. Securities and Exchange Commission. Registration does not imply a certain level of skill or training. More information about BFO’s investment advisory services can be found in its Form ADV Part 2, which is available upon request.